Professor Benoit Arsenault, Laval University, Québec, Canada, looks at the pathological mechanisms through which Lp(a) contributes to the development of calcific aortic valve stenosis, and reviews remaining questions about the potential impact of Lp(a) reduction.
Educational Partners and Supporters
Novartis has provided with arm’s length sponsorship towards the set-up of the Lp(a) Forum. The content was developed independently by the Forum.
(Founding Partner)